TrialFrontiers in immunology2021

KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer.

Elena Muraro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.